BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33224891)

  • 1. Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis.
    Zhang S; Liu Z; Wu D; Chen L; Xie L
    Front Oncol; 2020; 10():596318. PubMed ID: 33224891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor-infiltrating B cells in the tumor microenvironment of hepatocellular carcinoma and its prognostic value: a bioinformatics analysis.
    Zou J; Luo C; Xin H; Xue T; Xie X; Chen R; Zhang L
    J Gastrointest Oncol; 2022 Aug; 13(4):1959-1966. PubMed ID: 36092319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell RNA-seq Analysis Reveals Dysregulated Cell-Cell Interactions in a Tumor Microenvironment Related to HCC Development.
    Liu Z; Zhang S; Ouyang J; Wu D; Chen L; Zhou W; Xie L
    Dis Markers; 2022; 2022():4971621. PubMed ID: 35634447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    He Z; Peng C; Li T; Li J
    Front Genet; 2022; 13():858905. PubMed ID: 35360852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma.
    Duan J; Zhu P; Zhang Y; Mu T; Li Y; Xiong R; Chen S; Li Y; Li Z; Chen S; Zhang L
    J Clin Transl Hepatol; 2023 Aug; 11(4):850-862. PubMed ID: 37408821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx.
    Li L; Shen L; Ma J; Zhou Q; Li M; Wu H; Wei M; Zhang D; Wang T; Qin S; Xing T
    Front Med (Lausanne); 2020; 7():451. PubMed ID: 33043022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zeng XC; Zhang L; Liao WJ; Ao L; Lin ZM; Kang W; Chen WN; Lin X
    Front Genet; 2020; 11():555537. PubMed ID: 33193629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells.
    Yao F; Zhan Y; Li C; Lu Y; Chen J; Deng J; Wu Z; Li Q; Song Y; Chen B; Chen J; Tian K; Pu Z; Ni Y; Mou L
    Front Cell Dev Biol; 2021; 9():734287. PubMed ID: 35059393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma.
    Rao J; Wu X; Zhou X; Deng R; Ma Y
    Front Genet; 2020; 11():575776. PubMed ID: 33193690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
    Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
    Front Genet; 2020; 11():593273. PubMed ID: 33193737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.
    Zhao Y; Xue F; Sun J; Guo S; Zhang H; Qiu B; Geng J; Gu J; Zhou X; Wang W; Zhang Z; Tang N; He Y; Yu J; Xia Q
    Clin Epigenetics; 2014; 6(1):30. PubMed ID: 25859288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.
    Tamura I; Kurimura O; Koda T; Ichimura H; Katayama S; Kurimura T; Inaba Y
    J Gastroenterol Hepatol; 1993; 8(5):433-6. PubMed ID: 8218990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
    Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
    Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.